http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008106177-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e96fa8109736a485524a8536f4bf231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fcb093a174d5182b5854b704cb09354
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebf0b76fff057891f6729cf3137f94d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed728f952b9a3367bb1da8b34f64cc78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09692181751eb7f63ef071fc34d9018b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba1a921b4868fde3bb08aa2f7c181e4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_280d87031f0c5786de1808713a1b76b7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-88
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-671
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21
filingDate 2008-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a76ef7ecd80c404703097b057dffd6e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2479a6a9fc41fc39d2d8edf7e2c92b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c960b1e391d8ee2f31dd62baf2452858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54530dcdb70dc5148fadcdcb36ab1478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a44da792bb6e7edb3a78d65afd755fd7
publicationDate 2008-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008106177-A3
titleOfInvention Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy
abstract The invention relates to the use of nicotinic acid alkyl esters, especially myristyl nicotinate, to inhibit side effects associated with retinoic acid therapy. Also a part of the invention is a method for improving skin cell differentiation by administering the nicotinic acid alkyl ester in an amount sufficient to increase expression of caspase 14 and filaggrin. Deficiencies in expression of these molecules can be treated in this way as well.
priorityDate 2007-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002137693-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6677361-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007009474-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226503289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID531641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18546028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226503290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID938

Total number of triples: 43.